Published in Hepatitis Weekly, November 7th, 2005
According to recent research published in the Journal of Clinical Virology, "until the mandatory introduction of viral inactivation techniques of blood plasma products in the early 1980s many recipients of these products were infected with various viral pathogens."
B. Kupfer and colleagues, University of Cologne conducted research "to determine the rate of transmission of GB virus C/hepatitis G virus (GBV-C/HGV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) through non-virus-inactivated clotting factor concentrates in hemophiliacs, as well as the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-11-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.